Prostate-Specific Antigen (PSA) Test - NCI Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise The PSA test measures the level of PSA in the blood
Prueba del antígeno prostático específico (PSA) The single-parameter, structure-based IsoPSA assay demonstrates improved diagnostic accuracy for detection of any prostate cancer and high-grade prostate cancer compared to a concentration-based assay of total prostate-specific antigen: A preliminary report
Prostate Cancer Screening - NCI A prostate-specific antigen (PSA) test is a test that measures the level of PSA in the blood PSA is a substance made mostly by the prostate that may be found in an increased amount in the blood of men who have prostate cancer
Understanding Prostate Changes - NCI - National Cancer Institute Based on your symptoms, your doctor may advise a digital rectal exam, blood tests such as the prostate-specific antigen (PSA) test, and a urinalysis Your doctor may refer you to a urologist, a doctor who specializes in diagnosing and treating diseases of the urinary and reproductive organs in males and the urinary organs in females
Prostate Cancer Screening (PDQ®) - NCI Prostate cancer screening with the prostate-specific antigen (PSA) test or digital rectal exams has not been shown to reduce prostate cancer deaths Get detailed information about prostate cancer screening, including potential benefits and harms, in this summary for clinicians
PSA (Prostatic Specific Antigen) Lab Value | EOD Data SEER*RSA Description PSA (Prostatic Specific Antigen) is a protein produced by cells of the prostate gland and is elevated in patients with prostate cancer This data item pertains to PSA lab value Serum PSA is the most sensitive tumor marker for monitoring individuals with prostate cancer, including progression of disease and response to therapy
Prostate Cancer Screening | Cancer Trends Progress Report Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland The PSA test measures the level of PSA in a man’s blood For this test, a blood sample is sent to a laboratory for analysis In 2012 the U S Preventive Services Task Force (USPSTF) recommended against prostate cancer screening In May 2018, the USPSTF published a final
Prostate-Specific Antigen (PSA) Testing - Landmark Studies The prostate-specific antigen (PSA) test was approved by the U S Food and Drug Administration in 1986 for monitoring disease status in men with prostate cancer and in 1992 for diagnosis
An Improved Prostate Cancer Biomarker Test May Help Men Avoid . . . Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those who can wait The 18-gene test, called MyProstateScore version 2 0, or MPS2, improves upon the earlier version of MyProstateScore (MPS), the validated two-gene algorithm